News & Press: Breaking News

ISCT Publishes Article in Translational Scientist Concerning the US REGROW Act

Friday, December 2, 2016  
Share |

ISCT Chief Regulatory Officer, Karen Nichols, Esq., and ISCT Mesenchymal Stem Cell Committee Chair, Jacques Galipeau, MD, recently published the article entitled "Speed Versus Safety for Cell Therapy" in The Translational Scientist journal, addressing concerns about the US REGROW Act. To read the article, please click here

For more information on the ISCT Presidential Task Force on the Use of Unproven Cellular Therapies, please click here


© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.